Skip to content
Search

Latest Stories

Mosquito-borne infections returning to pre-pandemic levels, UKSHA warns travellers

Mosquito-borne infections returning to pre-pandemic levels, UKSHA warns travellers

People who are planning to travel abroad are advised to check the Travel Health Pro website for information on health risks in countries across the world.

The UK Health Security Agency’s (UKHSA) has advised travellers to take precautions to reduce the risk of contracting travel-associated mosquito-borne infections, such as dengue, malaria and Zika, while abroad.


Data released by the agency shows that travel-associated infections are returning to pre-pandemic levels in the UK, with many confirmed cases reported from individuals who had recently been abroad.

According to the UKHSA, 634 dengue cases were reported last year in returning travellers across England, Wales and Northern Ireland, matching closely with the figures from 2019, the pre-pandemic period, when 790 cases were reported.

The majority of reported dengue cases were acquired in Southern Asia and South-Eastern Asia, particularly India. Concerningly, there has been an increase in cases contracted in Central America and the Caribbean, resulting from recent outbreaks in these parts of the world.

A significant rise in global dengue cases was reported in 2023, with the World Health Organization (WHO) estimating over five million cases and 5000 deaths worldwide.

From January to October 2023, a total of 1,637 malaria cases were confirmed in England, similar to the 1,719 cases reported in the UK in 2019 and closely aligning with the average of 1,612 cases reported between 2010 and 2019.

As per the WHO, global malaria cases reached an estimated 249 million in 2022, surpassing pre-pandemic levels by 16 million compared to 2019.

Although Zika cases are low in the country, the health agency has cautioned that the infection can pose a particular risk to pregnant women and those trying to conceive.

In 2023, eight Zika cases were reported in England, a similar level to 2022. The highest number of cases was reported in 2016, totaling 725 cases, coinciding with the Zika outbreak in America that year.

Dr Philip Veal, consultant in public health at the UKHSA, highlighted that the surge in serious mosquito borne infections resulted from the rise in travel following the lifting of travel restrictions during the pandemic.

He suggested some simple steps that people can take to reduce the risk of these infections such as:

  • Prevent mosquito bites by using insect repellent, covering exposed skin and sleeping under a treated bed net.
  • Plan ahead and visit the TravelHealthPro website to look up your destination and the latest health information and advice.

“Even if you have visited or lived in a country before, you will not have the same protection against infections as local people and are still at risk,” he said.

People who are planning their trip abroad are advised to check the Travel Health Pro website, supported by the UKHSA, for information on health risks in countries across the world.

It is advisable for travellers to consult their GP, practice nurse, pharmacist, or travel clinic 4 to 6 weeks before their trip for individual advice, travel vaccines and malaria prevention tablets, if deemed necessary for their destination.

Additionally, travellers are being informed to watch out for symptoms associated with mosquito-borne infections including fever, severe headache, pain behind the eyes, in muscles, joints and abdomen, loss of appetite, nausea and vomiting.

“When you return to the UK, if you feel unwell, seek medical attention and ensure you inform your healthcare provider that you have been travelling recently,” said Dr Dipti Patel, Director of the National Travel Health Network and Centre.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less